Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell‐derived extracellular vesicles. Issue 2 (26th June 2017)

• Record Type: Journal Article
• Authors: Patel, Divya B.; Gray, Kelsey M.; Santharam, Yasasvhinie; Lamichhane, Tek N.; Stroka, Kimberly M.; Jay, Steven M.
• Is Part Of: Bioengineering & translational medicine. Volume 2:Issue 2(2017)
• Page Start: 170
• Page End: 179
• Publication Date: 2017-06-26
• Subjects: biomanufacturing -- EVs -- exosomes -- mesenchymal stem cells -- therapeutic angiogenesis; Bioengineering -- Periodicals; Drug development -- Periodicals; Drugs -- Testing -- Periodicals; 660.6
• DOI: 10.1002/btm2.10065
• Languages: English
• ISSNs: 2380-6761

Abstract

Abstract: Mesenchymal stem cell (MSC)‐derived extracellular vesicles (EVs) have emerged as potential therapeutic agents for numerous applications. EVs offer potential advantages over cell‐based therapies with regard to safety, stability and clearance profiles, however production and potency limitations must be addressed to enable eventual translation of EV‐based approaches. Thus, we sought to examine the role of specific cell culture parameters on MSC EV production and bioactivity toward informing rational design parameters for scalable EV biomanufacturing. We report significantly reduced MSC EV vascularization bioactivity, as measured by an endothelial cell gap closure assay, with increasing passage in culture by trypsinization, especially beyond passage 4. We further show that increased frequency of EV collection yielded higher numbers of EVs from the same initial number of MSCs over a 24 hr period. Finally, we demonstrate that decreased cell seeding density in culture flasks resulted in increased production of EVs per cell in MSCs and other cell types. Overall, these studies highlight the need for careful consideration of the parameters of cell passage number and cell seeding density in the production of therapeutic EVs at laboratory scale and for rational design of large‐scale EV biomanufacturing schemes. Abstract : Production and bioactivity of mesenchymal stem cell (MSC)‐derived extracellular vesicles (EVs) are impacted by cell passage and seeding density, indicative that these parameters should be carefully considered toward rational design of a scalable biomanufacturing pathway for therapeutic exosomes and other EVs.